Small vessel disease lesion type and brain atrophy: The role of co-occurring amyloid

13Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: It is unknown whether different types of small vessel disease (SVD), differentially relate to brain atrophy and if co-occurring Alzheimer's disease pathology affects this relation. Methods: In 725 memory clinic patients with SVD (mean age 67 ± 8 years, 48% female) we compared brain volumes of those with moderate/severe white matter hyperintensities (WMHs; n = 326), lacunes (n = 132) and cerebral microbleeds (n = 321) to a reference group with mild WMHs (n = 197), also considering cerebrospinal fluid (CSF) amyloid status in a subset of patients (n = 488). Results: WMHs and lacunes, but not cerebral microbleeds, were associated with smaller gray matter (GM) volumes. In analyses stratified by CSF amyloid status, WMHs and lacunes were associated with smaller total brain and GM volumes only in amyloid-negative patients. SVD-related atrophy was most evident in frontal (cortical) GM, again predominantly in amyloid-negative patients. Discussion: Amyloid status modifies the differential relation between SVD lesion type and brain atrophy in memory clinic patients.

Cite

CITATION STYLE

APA

Heinen, R., Groeneveld, O. N., Barkhof, F., de Bresser, J., Exalto, L. G., Kuijf, H. J., … Biessels, G. J. (2020). Small vessel disease lesion type and brain atrophy: The role of co-occurring amyloid. Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring, 12(1). https://doi.org/10.1002/dad2.12060

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free